In this video, Mark Zimmerman, MD, discusses why borderline personality disorder (BPD) is under-recognized, comorbid conditions in BPD, when patients should be screened for BPD, and tools for screening for BPD.
NEW YORK CITY—A single treatment of botulinum toxin injections vastly improved treatment-resistant symptoms of borderline personality disorder in at least 10 consecutive cases, according to new research.
Lamotrigine is neither clinically effective nor cost-effective for the treatment of borderline personality disorder (BPD) in adults, according to a study published online in The American Journal of Psychiatry.
People with borderline personality disorder (BPD) have greater asymmetry in the frontolimbic cortex of the brain than healthy individuals do, researchers from China found in a study published online in Acta Psychiatrica Scandinavica.
John M. Oldham, MD, MS, will give a full overview of the Alternative Model for DSM-5 Personality Disorders (AMPD), and explain how clinicians can use it, during his session at Psych Congress.
One in 5 patients with bipolar disorder also has borderline personality disorder, and identifying both in the same patient can be tricky, Mark Zimmerman, MD, told attendees at Psych Congress.